0001493152-24-030970.txt : 20240809 0001493152-24-030970.hdr.sgml : 20240809 20240809160533 ACCESSION NUMBER: 0001493152-24-030970 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240805 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ainos, Inc. CENTRAL INDEX KEY: 0001014763 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 751974352 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41461 FILM NUMBER: 241192566 BUSINESS ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 BUSINESS PHONE: 858-869-2986 MAIL ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 FORMER COMPANY: FORMER CONFORMED NAME: AMARILLO BIOSCIENCES INC DATE OF NAME CHANGE: 19960516 8-K 1 form8-k.htm
false 0001014763 0001014763 2024-08-05 2024-08-05 0001014763 AIMD:CommonStockParValue0.01PerShareMember 2024-08-05 2024-08-05 0001014763 AIMD:WarrantsToPurchaseCommonStockMember 2024-08-05 2024-08-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 5, 2024

 

AINOS, INC.
(Exact name of registrant as specified in its charter)

 

Texas   001-41461   75-1974352

(State or other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

8880 Rio San Diego Drive, Ste. 800, San Diego, CA 92108

(858) 869-2986

(Address and telephone number, including area code, of registrant’s principal executive offices)

 

(Former name or former address if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01 per share   AIMD   The Nasdaq Stock Market LLC
Warrants to purchase Common Stock   AIMDW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Patent License Agreement

 

On August 6, 2024, Ainos, Inc., a Texas corporation (the “Company”) entered into a patent license agreement (the “License Agreement”) with Taiwan Carbon Nano Technology Corporation (“TCNT”), as an effort to bolster the Company’s AI Nose and point-of-care testing (POCT) technologies while preserving cash. As of August 5, 2024, prior to TCNT entering into the License Agreement, TCNT controlled, via its majority interest in Ainos Inc., a Cayman Islands corporation (“Ainos KY”) which is a party to certain previously disclosed Voting Agreements, approximately 38% of the voting power of the Company. Pursuant to the License Agreement, TCNT has agreed to assign and grant, and the Company has agreed to accept, an exclusive, irrevocable, and perpetual license of certain invention patents and patent applications related to gas sensors and medical devices (the “Licensed Patents”), in exchange for 5,500,000 shares of the Company’s common stock (the “Common Stock”), par value $0.01 per share, which is listed on the Nasdaq Capital Market under the symbol “AIMD,” at a price per share of 1.05 times the highest closing sale price of the Common Stock during the 30-trading day period preceding the effective date of the License Agreement. The License Agreement shall remain in effect until terminated by mutual written agreement of the parties, or until the expiration of the Licensed Patents, or all claims for alleged infringement of the Licensed Patents are barred by applicable laws.

 

Following the issuance of the 5.5 million shares of stock, TCNT will control approximately 63.2% of the voting power of the Company. TCNT plans to enter into a voting agreement with Ainos KY and, pursuant to such voting agreement, will agree to vote all of the voting stock of the Company that is current owns or will acquire in the future in the manner determined by Ainos KY in its sole discretion.

 

The foregoing description of the License Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the License Agreement, a copy of which is filed with this current report on Form 8-K as Exhibit 10.1 and is hereby incorporated herein by reference.

 

Item 3.02 Unregistered Sales of Equity Securities

 

As described in Item 1.01 above, the Company entered into the License Agreement on August 6, 2024, and agreed to issue 5,500,000 shares of Common Stock to TCNT in connection with the transaction contemplated by the License Agreement. The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02.

 

Note Conversion

 

As previously reported, on September 25, 2023, the Company entered into a securities purchase agreement with Lind Global Fund II LP (“Lind”) and issued a senior secured convertible promissory note, as amended on January 23, 2024 (the “Note”) to Lind. On August 5, 2024, the Company fully prepaid the remaining outstanding principal of the Note, totaling $1.67 million. The prepayment was made with $1,439,754 in cash and $224,842 through the issuance of 382,384 shares of Common Stock, valued at $0.588 per share.

 

The issuances of the securities were made without registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemption provided by Section 4(a)(2) of the Securities Act as a transaction not involving a public offering.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

As of August 9, 2024, Lawrence K. Lin transitioned from his role as the Company’s Executive Vice President of Operations, effective August 9, 2024. As a result of this transition, Mr. Lin no longer serves as an executive officer of the Company.

 

Item 9.01 Financial Statement and Exhibits

 

(d) Exhibits.

 

Exhibit No.   Description
10.1   Patent License Agreement, dated August 6, 2024, by and between Ainos, Inc. and Taiwan Carbon Nano Technology Corporation.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Ainos, Inc.
     
Date: August 9, 2024 By: /s/ Chun-Hsien Tsai
  Name: Chun-Hsien Tsai
  Title: Chief Executive Officer

 

3

 EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

Patent License Agreement

 

This Patent License Agreement (this “Agreement”) is made and entered into as of the Effective Date of August 6, 2024, in two original counterparts, by and between Taiwan Carbon Nano Technology Corporation (“LICENSOR”), a Taiwan company having an office and place of business at 10F-2, No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302 , Taiwan (R.O.C.) and Ainos, Inc. (“LICENSEE”), a Texas corporation, having an office and place of business at 8880 Rio San Diego Drive Suite 800 San Diego, CA 92108, U.S.A..

 

LICENSOR and LICENSEE are referred to herein individually as a “Party” and collectively as the “Parties”.

 

RECITALS

 

WHEREAS, LICENSOR owns and controls certain patents in the field of gas sensors and medical devices.

 

WHEREAS, LICENSOR desires to grant LICENSEE licenses to the technologies covered by its patents on the terms and conditions of this Agreement.

 

WHEREAS, LICENSEE desires to obtain such licenses from LICENSOR on the terms and conditions of this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and obligations undertaken herein, LICENSOR and LICENSEE agree as follows:

 

Article I. Definitions.

 

1.1.“Affiliates” shall mean with respect to any Person, any other Person (a) that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with such Person or (b) is at least fifty percent (50%) beneficially owned by such Person. For the purpose of this definition, the term “control” (including with correlative meanings, the terms “controlling”, “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or other ownership interests, by contract or otherwise.

 

1.2.“LICENSOR” shall have the meaning assigned to such term in the preamble, and includes its past, present or future divisions, and Affiliates.

 

1.3.“LICENSEE” shall have the meaning assigned to such term in the preamble, and includes its past, present or future divisions, affiliates and Subsidiaries (as defined below).

 

1.4.“Licensed Patents” shall mean all patents and patent applications listed in Schedule A attached hereto.

 

1.5.“Person” means an individual, general partnership, limited partnership, limited liability company, corporation, trust, estate, real estate investment trust, association or any other entity.

 

1

 

 

1.6.“Products” shall mean any and all past, present and future products manufactured or sold by or for LICENSEE, or used, leased, sold, offered for sale, imported, exported or otherwise disposed of by LICENSEE, which may have been previously covered by, are now covered by or in the future are covered by one or more claims of the Licensed Patents, or which are manufactured by or utilize a method covered by one or more claims of the Licensed Patents and, but for the rights, licenses, privileges, releases, non-assertions and immunities granted hereunder, would or could be alleged to infringe directly or indirectly, by contributory infringement, by inducement or otherwise, one or more claims of the Licensed Patents.

 

1.7.“Effective Date” shall mean the last of the dates, if different, on which this Agreement is executed by LICENSOR and LICENSEE, which Effective Date will be entered in the preamble of this Agreement in accordance with para. 8.7 hereof.

 

Article II. Licenses, Releases and Non-Assertions.

 

2.1.LICENSOR, on behalf of itself and any successors and/or assigns, grants to LICENSEE, and LICENSEE hereby accepts, an exclusive, irrevocable and perpetual right, license, privilege and immunity, with the right to grant sublicenses only to LICENSEE’s Affiliates, under all claims of the Licensed Patents, to make, have made, use, sell, offer for sale, lease, import, export or otherwise dispose of Products throughout the world.

 

2.2.LICENSOR hereby releases and discharges LICENSEE, as well as any end-users, distributors, customers, dealers and suppliers of LICENSEE, whether direct or indirect, or immediate or remote, throughout the world, from any and all actions, causes of action, claims or demands whatsoever in law or equity as to all claims for patent infringement, direct and/or contributory and/or by inducement or otherwise, which LICENSOR has or may have had at any time prior to the Effective Date, which could be asserted against LICENSEE, or against any of LICENSEE’s end-users, distributors, customers, dealers and suppliers of LICENSEE, whether direct or indirect, or immediate or remote, arising out of the manufacture, having manufactured, use, sale, offer for sale, lease, import, export or other disposition of Products.

 

Article III. LICENSE FEE AND OTHER PaymentS.

 

3.1.In consideration of the rights, licenses, privileges, releases, non-assertions and immunities granted by LICENSOR under this Agreement, LICENSEE agrees to issue to LICENSOR five million and five hundred thousand (5,500,000) shares of LICENSEE’s common stock, which shall be valued at and on the basis of the following:

 

Y = (X * 1.05) * 5,500,000

 

Whereas:

 

Y is the aggregate value of the shares of LICENSEE common stock issued under para. 3.1 (the “License Fee”); and

 

X is the highest closing price of LICENSEE’s common stock quoted on the Nasdaq Stock Market during the 30-trading days period preceding the Effective Date.

 

2

 

 

3.2.Except for payments provided in this Article III, LICENSOR agrees that there is and will be no payment of any kind from LICENSEE which is due or which would become due or is to be made hereafter in connection with this Agreement, including any payments to LICENSOR’s successors or assignees of any of the Licensed Patents or to its counsel.

 

Article IV. Term, Renewal and Survival.

 

4.1.The term of this Agreement, as well as the term of the rights, licenses, privileges, immunities, releases and non-assertions granted herein under the Licensed Patents as set forth in Article II, shall exist from, and including, the Effective Date and shall remain in effect:

 

(a)until this Agreement is terminated by mutual written agreement of the Parties; or

 

(b)(i) to and including the expiration date of the last to expire of the Licensed Patents, or (ii) until all claims for alleged infringement of all of the Licensed Patents are barred by U.S. laws and the U.S. Patent Statute and by the laws and statutes of any foreign country in which any one of the Licensed Patents are in force and effect, whichever is longer.

 

4.2.For the avoidance of doubt, any expiration or termination of certain parts of the Licensed Patents that are licensed to LICENSEE under this Agreement shall not be deemed to be an expiration or termination of this Agreement, unless all of the Licensed Patents licensed hereunder have expired or terminated or have become invalid.

 

4.3.The following provisions will survive termination or expiration of this Agreement: Articles Article I, Article III, Article V, Article VI, Article VII and Article VIII and this para. 4.1(b).

 

Article V. Warranties, Representations and Disclaimers.

 

5.1.LICENSEE warrants and represents that it has the right to enter into this Agreement with LICENSOR.

 

5.2.LICENSOR makes the following warranties and representations:

 

(a)LICENSOR is the owner of the Licensed Patents and/or has the right to grant rights, licenses, privileges, releases, non-assertions and immunities under or relating to the Licensed Patents. In the event LICENSOR breaches this warranty and representation, it will indemnify LICENSEE and, without limitation, at LICENSOR’s own expense shall secure any rights necessary for LICENSEE to enjoy the rights, licenses, privileges, releases, non-assertions and immunities granted herein under or relating to the Licensed Patents.

 

(b)LICENSOR has the full power to enter into and perform all terms, conditions and obligations under this Agreement with LICENSEE. To the extent required, LICENSOR shall obtain any and all needed consents for entering into and discharging all of its obligations under this Agreement.

 

(c)There are no liens, conveyances, mortgages, assignments, encumbrances, other licenses, or other agreements which would prevent or impair the full and complete exercise of the rights, licenses, privileges, releases, non-assertions and immunities granted by LICENSOR to LICENSEE, its respective successors and assigns, customers, whether immediate or remote, and suppliers with respect to the Licensed Patents pursuant to the specific terms and conditions of this Agreement.

 

3

 

 

(d)No agreements have been or shall be entered into which would interfere with the rights, licenses, privileges, releases, non-assertions and immunities granted by LICENSOR to LICENSEE, its respective successors and assigns, or its customers, whether immediate or remote, and its suppliers with respect to the Licensed Patents during the full term as set forth in para. 4.1.

 

5.3.Nothing herein contained shall be construed as an admission by LICENSEE, its distributors, dealers, suppliers, agents, or customers, whether direct or indirect, or immediate or remote that (i) there has been direct and/or contributory infringement of, and/or inducement to infringe, the Licensed Patents hereunder, or (ii) the Licensed Patents are valid.

 

Article VI. Confidentiality and Publicity.

 

6.1.Neither Party will issue a press release after the execution of this Agreement, unless the other Party has approved the contents of such press release in writing in advance of its release to the public. LICENSEE shall have the right to refer to the existence of this Agreement and to disclose the substance thereof, but not the amount of the payments, in response to any inquiry by any distributor, dealer, supplier, agent or customer, whether direct or indirect, or immediate or remote, to the extent deemed reasonably necessary by LICENSEE, to conduct its business on or in connection with or relating to its products. LICENSOR may refer to the existence of this Agreement incident to their continued licensing and enforcement of the Licensed Patents but shall not disclose or publicize the terms and conditions of this Agreement.

 

6.2.Each Party agrees that, during and after the term of this Agreement, it shall not publicize the existence of or otherwise disclose this Agreement, or the terms and conditions hereof, except: (i) as permitted under para. 6.1 above; (ii) with the prior written consent of the other Party; or (iii) pursuant to an order or directive of a court or other governmental body having jurisdiction to call therefor; or (iv) in the enforcement of the Licensed Patents, but subject to the existence of a protective order in any such litigation which would be acceptable to LICENSEE; or (v) as may be required by law; or (vi) as may be necessary to establish or assert its rights hereunder. With regard to the above-mentioned exceptions (iii) through (vi), the disclosing party (a) shall give prior written notice to the other party, (b) shall not disclose this Agreement until twenty (20) business days after such written notice, and (c) shall make its best efforts to ensure that the disclosure is made pursuant to the highest level of confidentiality afforded by the applicable protective order or other governing agreement, order or regulation.

 

Article VII. Arbitration.

 

Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be finally settled by a binding arbitration administered by the American Arbitration Association under its Commercial Arbitration Rules (or Patent Arbitration Rules if applicable), and judgment on any award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The arbitration shall be conducted in Dallas County, Texas under the laws of the State of Texas in English before one (1) arbitrator who shall render a reasoned award and who may make an award of reasonable attorneys’ fees to the prevailing party. If not mutually agreed upon, the arbitrator shall be selected according to the American Arbitration Association Rules from among persons having patent expertise in the subject matter of this Agreement. The parties may exercise reasonable discovery rights in any such arbitration and the arbitrator will be instructed to follow applicable rules of substantive law in deciding the dispute.

 

4

 

 

Article VIII. Other Provisions.

 

8.1.LICENSEE shall have the financial responsibility to pay the maintenance fees for maintaining the effectiveness of the Licensed Patents and to use its best efforts to take any other appropriate maintenance actions for maintaining the effectiveness of the Licensed Patents in accordance with applicable laws and commercial standards. LICENSOR shall take such actions as may be necessary to allow and permit LICENSEE to take any appropriate maintenance action relating to the Licensed Patents, including designating LICENSEE as the agent or attorney or record for such Licensed Patents. . In the event that LICENSOR determines that it is not in its best interests to have any of the Licensed Patents to continued to be maintained (each such Licensed Patent a “Forfeited Patent”) and the LICENSOR notifies the LICENSEE of its intent in writing, LICENSOR shall transfer title and ownership of such Forfeited Patent to the LICENSEE at no additional costs and the LICENSEE shall thereafter determine at its sole discretion whether or not to continue maintaining such Forfeited Patent at its own cost.

 

8.2.If any of the provisions of this Agreement shall contravene the laws of any country, it is agreed that such invalidity or illegality shall not invalidate this Agreement, but instead this Agreement shall be construed as if it did not contain the provision(s) claimed or held to be invalid or illegal in the particular jurisdiction concerned, insofar as such construction does not materially affect the substance of this Agreement, and the rights and obligations of the parties hereto shall be construed and enforced accordingly. In the event, however, that such claimed invalidity or illegality shall substantially alter the relationship between the parties hereto, materially affecting adversely the interest of either party in such jurisdiction, then the parties hereto shall negotiate an alternative provision not conflicting with such laws so as to maintain, to the degree reasonably possible, the business and economic benefits and liabilities as initially set forth herein. If such invalidity or illegality is such that it is not possible to reasonably restore the business and economic benefits and liabilities of the parties, then the party whose interests are adversely affected shall have the right to terminate only that portion of this Agreement that is materially impacted by such invalidity or illegality.

 

8.3.The terms of this Agreement shall be binding upon the direct or indirect successors or assigns of the parties.

 

8.4.This Agreement sets forth the entire understanding of the parties relating to the subject matter hereof and cancels and supersedes all other agreements or understandings leading up to the execution of this Agreement. No amendment or modification of this Agreement shall be valid or binding upon the parties unless made in writing and signed on behalf of the parties by their respective duly authorized representatives.

 

5

 

 

8.5.In the event of a transfer or assignment of one or more of the Licensed Patents by LICENSOR, the assignee thereof shall take such assignment subject to the rights, licenses, privileges, releases, non-assertions and immunities granted under this Agreement. If LICENSEE transfers and sells to a third party a substantial portion of its business to which the Licensed Patents relate, LICENSEE may assign its rights under this Agreement upon written notice to LICENSOR and the assignee thereof shall take such assignment and receive the rights, licenses, privileges, releases, non-assertions and immunities granted under this Agreement, provided however, that the rights, licenses, privileges, releases, non-assertions and immunities provided to LICENSEE under this Agreement shall not apply to any products of the assignee being manufactured or sold prior to such transfer or assignment. Any Subsidiary or division of LICENSEE that is divested shall continue to retain its rights, licenses, privileges, releases, non-assertions and immunities granted under this Agreement.

 

8.6.No act, delay or omission by any party shall be deemed a waiver of any right, power, or remedy of such party unless such waiver is in writing, and then only to the extent set forth therein. All remedies, either under this Agreement or by law or otherwise afforded to a party, shall be cumulative and not alternative. No waiver of any provision, right or remedy under this Agreement on any one occasion shall constitute a waiver of any other provision, right or remedy on said occasion or the same or any other provision, right or remedy on any other occasion.

 

8.7.This Agreement shall be executed in two originals by the parties. This Agreement will first be executed by LICENSOR, with two executed originals delivered to counsel for LICENSEE. Upon receipt of this Agreement as executed by LICENSOR, LICENSEE will execute two originals of this Agreement and deliver one fully executed original to counsel for LICENSOR. The execution of this agreement by the parties shall be valid and binding as of the Effective Date which will be inserted in the preamble by LICENSEE.

 

8.8.All rights, licenses, privileges, releases, non-assertions and immunities granted under or pursuant to this Agreement by LICENSOR to LICENSEE are, and shall otherwise be deemed to be, for the purpose of Section 365(n) of the United States Bankruptcy Code, as amended (“the Bankruptcy Code”), licenses of rights to “intellectual property” as defined under Section 101 (35A) of the Bankruptcy Code. The parties hereto agree that LICENSEE, as licensee of such rights under this Agreement, shall retain and may fully exercise all of their rights and elections under the Bankruptcy Code. The parties hereto further agree that, if a Bankruptcy Code case is commenced by or against LICENSOR and this Agreement is rejected as provided in the Bankruptcy Code, then LICENSOR (in any capacity, including debtor-in-possession) and their successors and assigns (including, without limitation, a Bankruptcy Code trustee) shall take such steps as are necessary to permit LICENSEE to exercise all of their rights under this Agreement. All rights, powers and remedies of LICENSEE provided under this Article are in addition to and not in substitution for any and all other rights, powers and remedies now or hereafter existing at law or in equity (including, without limitation, the Bankruptcy Code) in the event of any such commencement of a bankruptcy proceeding by or against LICENSOR. LICENSEE, in addition to the rights, powers and remedies expressly provided herein, shall be entitled to exercise all other such rights and powers and resort to all other such remedies as may now or hereafter exist at law or in equity (including the Bankruptcy Code) in such event. LICENSOR acknowledges that the Payment represents at least equivalent value for the rights granted under this Agreement.

 

6

 

 

8.9.All notices required or permitted by this Agreement shall be in writing and shall be given by first class postage pre-paid mail, or by facsimile transmission, effective in each case upon the date of mailing or facsimile transmission thereof to the parties addressed as follows:

 

If to LICENSOR:

 

Taiwan Carbon Nano Technology Corporation

10F-2, No. 66, Shengyi 5th Rd.

Zhubei City, Hsinchu County 302 , Taiwan (R.O.C.)

 

Attn: Harry Lin
Email: [Redacted]

 

If to LICENSEE:

 

Ainos, Inc.

8880 Rio San Diego Drive, Suite 800

San Diego, CA 92108

U.S.A

 

Attn: Jack Lu
Email: [Redacted]

 

or to such other address as the party to receive such notice shall have designated by written notice to the other party hereto.

 

8.10.This Agreement shall be governed and construed and the relations between the Parties determined in all respects by the laws of the United States of America and the State of Texas without regard to any conflict of laws principles.

 

8.11.All titles used in this Agreement herein are for the convenience of reference only and shall not affect the construction of this Agreement.

 

7

 

 

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives as of the Effective Date.

 

LICENSOR:

 

TAIWAN CARBON NANO TECHNOLOGY CORPORATION

 

By: /s/ 蔡群賢  
     
Title: Chairman and CEO  
     
Date: August 6, 2024  

 

LICENSEE:

AINOS, INC.

 

By: /s/ Chun-Hsien Tsai  
     
Title: Chairman, President and CEO  
     
Date: August 6, 2024  

 

8

 

 

SCHEDULE A

 

LICENSED PATENTS

 

9

 EX-101.SCH 3 aimd-20240805.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 aimd-20240805_def.xml XBRL DEFINITION FILE EX-101.LAB 5 aimd-20240805_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.01 per share Warrants to purchase Common Stock Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 aimd-20240805_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Cover
Aug. 05, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 05, 2024
Entity File Number 001-41461
Entity Registrant Name AINOS, INC.
Entity Central Index Key 0001014763
Entity Tax Identification Number 75-1974352
Entity Incorporation, State or Country Code TX
Entity Address, Address Line One 8880 Rio San Diego Drive
Entity Address, Address Line Two Ste. 800
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92108
City Area Code (858)
Local Phone Number 869-2986
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock, par value $0.01 per share  
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol AIMD
Security Exchange Name NASDAQ
Warrants to purchase Common Stock  
Title of 12(b) Security Warrants to purchase Common Stock
Trading Symbol AIMDW
Security Exchange Name NASDAQ
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ainos.com/role/Cover Cover Cover 1 false false All Reports Book All Reports aimd-20240805.xsd aimd-20240805_def.xml aimd-20240805_lab.xml aimd-20240805_pre.xml form8-k.htm http://xbrl.sec.gov/dei/2024 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "AIMD", "nsuri": "http://ainos.com/20240805", "dts": { "schema": { "local": [ "aimd-20240805.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "aimd-20240805_def.xml" ] }, "labelLink": { "local": [ "aimd-20240805_lab.xml" ] }, "presentationLink": { "local": [ "aimd-20240805_pre.xml" ] }, "inline": { "local": [ "form8-k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 26 }, "report": { "R1": { "role": "http://ainos.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-08-05", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-08-05", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://ainos.com/role/Cover" ], "auth_ref": [] }, "AIMD_CommonStockParValue0.01PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://ainos.com/20240805", "localname": "CommonStockParValue0.01PerShareMember", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.01 per share" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "AIMD_WarrantsToPurchaseCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://ainos.com/20240805", "localname": "WarrantsToPurchaseCommonStockMember", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase Common Stock" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001493152-24-030970-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-030970-xbrl.zip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�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end XML 17 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001014763 2024-08-05 2024-08-05 0001014763 AIMD:CommonStockParValue0.01PerShareMember 2024-08-05 2024-08-05 0001014763 AIMD:WarrantsToPurchaseCommonStockMember 2024-08-05 2024-08-05 iso4217:USD shares iso4217:USD shares false 0001014763 8-K 2024-08-05 AINOS, INC. TX 001-41461 75-1974352 8880 Rio San Diego Drive Ste. 800 San Diego CA 92108 (858) 869-2986 false false false false Common Stock, par value $0.01 per share AIMD NASDAQ Warrants to purchase Common Stock AIMDW NASDAQ false